The latest price target for Agilon Health (NYSE:AGL) was reported by Deutsche Bank on August 9, 2024. The analyst firm set a price target for $4.00 expecting AGL to rise to within 12 months (a possible 4.17% upside). 30 analyst firms have reported ratings in the last year.

The latest analyst rating for Agilon Health (NYSE:AGL) was provided by Deutsche Bank, and Agilon Health maintained their hold rating.

There is no last upgrade for Agilon Health

The last downgrade for Agilon Health Inc happened on February 26, 2024 when TD Cowen changed their price target from $12 to $6.5 for Agilon Health Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on August 9, 2024 so you should expect the next rating to be made available sometime around August 9, 2025.

While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $5.00 to $4.00. The current price Agilon Health (AGL) is trading at is $3.84, which is out of the analyst’s predicted range.